Due to their small population, few resources and fewer clinical trials are devoted exclusively to patients with rare kidney cancer (also call "non clear cell renal cell carcinoma" or nccRcc).
TRI-CON, the molecular Medicine conference, is holding a hackathon on March 3rd and 4th, 2020 at Moscone Center in San Francisco in conjunction with Ben Busby, research to the people and rarekidneycancer.org. The hackathon free to attend,
